en
Scientific article
English

Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer

Published inEuropean journal of nuclear medicine and molecular imaging, vol. 39, no. 6, p. 936-943
Publication date2012
Abstract

To investigate the clinical value of (18)F-fluorocholine PET/CT (CH-PET/CT) in treatment decisions in patients with recurrent prostate cancer (rPCA).

Keywords
  • Adult
  • Aged
  • Choline/analogs & derivatives/diagnostic use
  • Humans
  • Male
  • Middle Aged
  • Positron-Emission Tomography and Computed Tomography
  • Prostate-Specific Antigen/metabolism
  • Prostatic Neoplasms/metabolism/radionuclide imaging/therapy
  • Recurrence
  • Retrospective Studies
Citation (ISO format)
SOYKA, Jan D et al. Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer. In: European journal of nuclear medicine and molecular imaging, 2012, vol. 39, n° 6, p. 936–943. doi: 10.1007/s00259-012-2083-2
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1619-7070
453views
1downloads

Technical informations

Creation10/31/2013 6:53:00 PM
First validation10/31/2013 6:53:00 PM
Update time03/14/2023 8:42:53 PM
Status update03/14/2023 8:42:52 PM
Last indexation01/16/2024 8:29:46 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack